The Chinese biotech company CanSino has been granted exclusive power to test their new coronavirus inoculation on Canadians.
CanSino's new Ad5-nCov coronavirus vaccine was jointly developed with the Academy of Military Science, which is the highest-level research institution for the People's Liberation Army of China.
While CanSino is a biotech company, they are in effect controlled by the Chinese president Xi Jinping, like all corporations in the communist state.
According to Reuters, China's Central Military Commission approved CanSino's use of the vaccine by their military for the next year:
“The Ad5-nCoV is currently limited to military use only and its use cannot be expanded to a broader vaccination range without the approval of the Logistics Support Department,” CanSino said, referring to the Central Military Commission department which approved the military use of the vaccine.
They then went silent when asked if the inoculation was mandatory or not.
So to recap – this vaccine is not proven, and it is still in testing.
But we have confirmed that this Chinese military product is on the shelves of Health Canada, ready for clinical trials.